NovaBay Pharmaceuticals

$0.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0697 (-8.01%) As of 4:48 PM UTC today

Why Robinhood?

You can buy or sell NBY and other stocks, options, and ETFs commission-free!

About NBY

NovaBay Pharmaceuticals, Inc., also called NovaBay Pharmaceuticals, is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA. The listed name for NBY is NovaBay Pharmaceuticals, Inc.

CEO
Justin M. Hall
Employees
28
Headquarters
Emeryville, California
Founded
2000
Market Cap
36.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
12.44M
High Today
$0.8871
Low Today
$0.7851
Open Price
$0.8801
Volume
828.83K
52 Week High
$1.94
52 Week Low
$0.24

NBY Earnings

-$0.15
-$0.10
-$0.05
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 25, After Hours

You May Also Like

KAMN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure